5/12/2015 | BKCVIG | S&P lowers Allergan
|
3/17/2015 | BKCVIG | Fitch cuts Allergan, affirms Actavis
|
3/5/2015 | IG | Market Commentary: Energy Transfer, Abbott, John Deere price; supply tops $60 billion; Coach, Microsoft firm
|
3/3/2015 | IG | Market Commentary: Actavis megadeal prices; Exxon upsizes; Exxon trades; AT&T firms; Verizon mixed
|
3/3/2015 | IG | Market Commentary: Morning Commentary: High-grade bonds stable; MetLife, Microsoft mostly flat in early trade
|
3/2/2015 | IG | Market Commentary: MetLife, Discover, American Airlines price; Actavis jumbo bond on deck; Discover, MetLife firm
|
11/17/2014 | IG | S&P affirms Actavis
|
11/17/2014 | BKBWIG | Actavis plans to issue $27.5 billion of new debt at an average of 4.25% to fund Allergan merger
|
11/17/2014 | IG | Moody’s affirms Actavis
|
7/1/2014 | BKHYIG | Moody's lifts Forest Labs from junk
|
7/1/2014 | BKHYIG | Fitch rates Forest Labs BBB-; affirms Actavis
|
6/10/2014 | IG | Market Commentary: Actavis, Johnson, RBC price, primary spree continues; new issues mixed in aftermarket trading
|
6/10/2014 | IG | New Issue: Actavis prices $3.7 billion of senior notes in four tranches
|
6/10/2014 | BKIG | Moody's rates Actavis notes Baa3
|
6/10/2014 | BKIG | S&P gives Actavis debt BBB-
|
6/10/2014 | BKIG | Fitch assigns Actavis bonds BBB-
|
6/10/2014 | IG | Actavis prepares to sell four-part offering of senior notes
|
3/5/2014 | BKIG | S&P rates Actavis loan BBB-
|
2/19/2014 | BKIG | Actavis gets commitment for bridge, term loans, notes to acquire Forest
|
2/19/2014 | IG | S&P downgrades Actavis
|
2/18/2014 | BKHYIG | Moody's might upgrade Forest Labs
|
2/18/2014 | BKIG | Actavis secures bridge loan for $25 billion acquisition of Forest Labs
|